Page last updated: 2024-11-02

pantoprazole and Hypoparathyroidism

pantoprazole has been researched along with Hypoparathyroidism in 3 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fatuzzo, P1
Portale, G1
Scollo, V1
Zanoli, L1
Granata, A1
Basterra-Gortari, FJ1
Goñi Iriarte, MJ1
Toni García, M1
Iriarte Beroiz, A1
Famularo, G1
Minisola, G1
Bravi, MC1
Colucci, P1
Gasbarrone, L1

Other Studies

3 other studies available for pantoprazole and Hypoparathyroidism

ArticleYear
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Journal of nephrology, 2017, Volume: 30, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements;

2017
[Asymptomatic hypomagnesemic hypoparathyroidism induced by pantoprazol].
    Medicina clinica, 2011, Oct-22, Volume: 137, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Humans; Hypoparathyroidism; Magnesium; Male; Pantopra

2011
Tetany, hypomagnesemia, and proton-pump inhibitors.
    The American journal of medicine, 2012, Volume: 125, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biomarkers; Female; Humans; Hypoparathyroidism; Magnesium;

2012